| Application | Comment | Organism |
|---|---|---|
| drug development | trials of 15LO1 pathway inhibitors in asthma may be a promising treatment strategy | Homo sapiens |
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| 6,11-dihydro[1]benzothiopyrano[4,3-b]indole | PD146176 | Homo sapiens | |
| siRNA | - |
Homo sapiens |
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| epithelial cell | in airway epithelial cells, 15LO1 expression increases with asthma severity and correlates with MUC5AC expression | Homo sapiens | - |
| Synonyms | Comment | Organism |
|---|---|---|
| 15-lipoxygenase 1 | - |
Homo sapiens |
| 15LO1 | - |
Homo sapiens |
| Organism | Comment | Expression |
|---|---|---|
| Homo sapiens | interleukin-13 induces 15LO1 expression and production of intracellular 15-hydroxyeicosatetraenoic acid conjugated to phosphotidylethanolamine in vitro. 15-hydroxyeicosatetraenoic acid enhances interleukin-13 induced MUC5AC expression in vitro | up |
| General Information | Comment | Organism |
|---|---|---|
| physiological function | high levels of 15LO1 activity can contribute to the increases of MUC5AC observed in asthma | Homo sapiens |